UNSPSC 51141586: Zoniclezole

This classification denotes an anticonvulsant agent with the molecular formula C12H10ClN3O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier H1C5F0K79E, chemically known as 1,2-benzisoxazole, 5-chloro-3-(1-(1h-imidazol-1-yl)ethyl)- but generally known as zoniclezole, which bears US NIH Compound Identifier 60745. European Medicines Agency schedules Zoniclezole in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB00186MIG.

UNSPSC 51141586 Zoniclezole, a Commodity code, shows minimal recent state and local procurement activity aligned to its nominal scope. The single recent opportunity on record—Seminole County, Florida's IFB60459723LAS, posted June 30, 2026—solicits naloxone and safe drug deactivation systems, not zoniclezole. The mismatch between the code name and the actual procurement suggests either miscoding in the county's system or that zoniclezole itself attracts no measurable state and local demand. Seminole County's IFB seeks 1,900 units of naloxone and 800 safe drug deactivation systems annually through competitive bidding, with quarterly deliveries to the Seminole County Community Health Building in Sanford, Florida. Vendors must include all shipping and delivery costs in their proposals, meet drug-free workplace and E-Verify requirements, maintain workers' compensation and general liability insurance, and comply with federal regulations including the Clean Air Act and Federal Water Pollution Control Act due to potential FEMA funding. The contract carries a two-year initial term with a one-year renewal option and a three-month probationary period allowing termination without cause.

Seminole County represents the only identifiable recent buyer under this code. The procurement is administered at the county level with deliveries consolidated to a single address in central Florida. With no other documented state or local solicitations under UNSPSC 51141586 in the recent-opportunities block, the code does not support a meaningful characterization of geographic spread or issuing-body diversity. If your firm supplies zoniclezole specifically to state or local health departments, emergency management agencies, or public safety organizations, this code warrants continued monitoring; the current record does not establish active demand.